CURATIS N AG - Asset Resilience Ratio

Latest as of June 2025: 3.75%

CURATIS N AG (CURN) has an Asset Resilience Ratio of 3.75% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore CURATIS N AG asset portfolio for the complete picture of this company's asset base.

Liquid Assets

CHF2.04 Million

≈ $2.59 Million USD Cash + Short-term Investments

Total Assets

CHF54.52 Million

≈ $68.93 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2022–2024)

This chart shows how CURATIS N AG's Asset Resilience Ratio has changed over time. See CURATIS N AG balance sheet quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down CURATIS N AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CURATIS N AG (CURN) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CHF2.04 Million	3.75%
Short-term Investments	CHF0.00	0%
Total Liquid Assets	CHF2.04 Million	3.75%

Asset Resilience Insights

Limited Liquidity: CURATIS N AG maintains only 3.75% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

CURATIS N AG Industry Peers by Asset Resilience Ratio

Compare CURATIS N AG's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Ajanta Pharma Limited NSE:AJANTPHARM	Drug Manufacturers - Specialty & Generic	14.99%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Guizhou Bailing Group Pharmaceutical Co Ltd SHE:002424	Drug Manufacturers - Specialty & Generic	2.09%
Dezhan HealthCare Co Ltd SHE:000813	Drug Manufacturers - Specialty & Generic	0.15%

Annual Asset Resilience Ratio for CURATIS N AG (2022–2024)

The table below shows the annual Asset Resilience Ratio data for CURATIS N AG.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	5.43%	CHF3.01 Million ≈ $3.81 Million	CHF55.54 Million ≈ $70.21 Million	+5.42pp
2022-12-31	0.01%	CHF1.00K ≈ $1.26K	CHF14.05 Million ≈ $17.76 Million	--

pp = percentage points

About CURATIS N AG

SW:CURN Switzerland Drug Manufacturers - Specialty & Generic

Market Cap

$153.71 Million

CHF121.58 Million CHF

Market Cap Rank

#19723 Global

#190 in Switzerland

Share Price

CHF23.60

Change (1 day)

-3.28%

52-Week Range

CHF10.45 - CHF26.00

All Time High

CHF891.52